Detalhe da pesquisa
1.
[Current challenges in the assessment of ethical proposals-aspects of digitalization and personalization in the healthcare system]. / Aktuelle Herausforderungen bei der Bewertung von Ethikanträgen Aspekte der Digitalisierung und Personalisierung im Gesundheitswesen.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 62(6): 758-764, 2019 Jun.
Artigo
em Alemão
| MEDLINE | ID: mdl-31073662
2.
Investigations on non-inferiority--the Food and Drug Administration draft guidance on treatments for nosocomial pneumonia as a case for exact tests for binomial proportions.
Stat Med
; 32(14): 2335-48, 2013 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-22991269
3.
On familywise type I error control for multiplicity in equivalence trials with three or more treatments.
Biom J
; 53(6): 914-26, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22069200
4.
A comparison of multiple testing procedures for the gold standard non-inferiority trial.
J Biopharm Stat
; 20(5): 911-26, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20721781
5.
Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019.
Eur J Cancer
; 130: 126-138, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32179447
6.
Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017.
Eur J Cancer
; 83: 247-257, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28756137
7.
Statistical strategies for the analysis of clinical trials with an experimental treatment, an active control and placebo, and a prespecified fixed non-inferiority margin for the difference in means.
Stat Med
; 30(26): 3162-4; author reply 3165, 2011 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22020727
8.
Survival of patients with advanced metastatic melanoma: The impact of novel therapies.
Eur J Cancer
; 53: 125-34, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26707829
9.
On testing simultaneously non-inferiority in two multiple primary endpoints and superiority in at least one of them.
Biom J
; 48(6): 916-33, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17240652
10.
Problems with existing procedures to calculate exact unconditional P-values for non-inferiority/superiority and confidence intervals for two binomials and how to resolve them.
Biom J
; 47(1): 37-47; discussion 99-107, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16395995
11.
On confidence bounds for the ratio of net differences in the "gold standard" design with reference, experimental, and placebo treatment.
Biom J
; 47(6): 799-806, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16450852
12.
Hypothesis testing in the "gold standard" design for proving the efficacy of an experimental treatment relative to placebo and a reference.
J Biopharm Stat
; 14(2): 315-25, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15206529
13.
Power and sample size determination when assessing the clinical relevance of trial results by 'responder analyses'.
Stat Med
; 23(21): 3287-305, 2004 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15490433
14.
Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo.
Stat Med
; 22(6): 883-99, 2003 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-12627407
15.
Adaptive designs: expectations are high.
Biom J
; 48(4): 491-2, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16972700
16.
"Testing superiority and non-inferiority hypotheses in active controlled clinical trials".
Biom J
; 48(1): 174-5; author reply 176, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16544822
17.
Minimization of sample size when comparing two small probabilities in a non-inferiority safety trial.
Stat Med
; 23(21): 3393-4; author reply 3395-6, 2004 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15493032